Atlas Trials

Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years

Clinical trial NCT05312294 · COMPLETED

Trial details

NCT number
NCT05312294
Sponsor
St. Petersburg Research Institute of Vaccines and Sera
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
InfluenzaFlu, Human
Start date
2020-12-07
Primary completion
2021-09-03
Enrollment
654

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.